Status:
TERMINATED
Investigation of a Sub-Conjunctival Insert
Lead Sponsor:
EyeSense GmbH
Conditions:
Diabetes Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is intended to evaluate a non-invasive method of glucose measurement in diabetics. The medical device that is evaluated consists on a sensor-insert which is placed under the conjunctiva of t...
Eligibility Criteria
Inclusion
- Be of legal age
- Insulin dependent diabetes requiring daily finger pricking to monitor blood glucose
- Sign written Informed Consent
Exclusion
- Inability to follow the protocol schedule
- Participating in another clinical study
- Pregnant or lactating females
- Any ongoing condition that would prevent from proper handling of the instrument (e.g. blindness, strong impaired vision, impaired motor skills)
- Any known hypersensitivity to any of the products to be used in the study, including preservatives etc.
- Malignancies requiring therapy during the study
- Severe chronic diseases e.g. renal failure, liver cirrhosis etc. which may interfere with the conduct or completion of the study
- Poorly controlled diabetes mellitus with prior hemoglobin A1C greater than 10%
- Any ocular disease requiring topical medication besides those permitted by this protocol.
- Ocular or other condition which increase the risk of ocular surgery, e.g. acute or chronic conjunctivitis or blepharitis, corneal disorders, previous eye surgery or eye surgery within the following 12 weeks, coagulation disorders.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00999856
Start Date
August 1 2008
End Date
May 1 2013
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Instiut Heidelberg
Heidelberg, Germany, 69115